Conference Summaries

The Body Covers: The 8th European Conference on Clinical Aspects and Treatment of HIV-Infection

Conference Summaries

October 28, 2001

Tipranavir: The First Non-Peptidic Protease Inhibitor
Coverage by Brian A. Boyle, M.D., J.D.
The Impact of First Line Therapies on Lipid Metabolism: The FRAMS Data
Coverage by Brian A. Boyle, M.D., J.D.
Switching From PI-Based to NNRTI-Based Regimens: Clinical and Metabolic Outcomes
Coverage by Brian A. Boyle, M.D., J.D.
One Week of Monotherapy with TMC-125, a Novel Highly Potent NNRTI, Produces a Mean 2-Log Reduction in Viral Load in Antiretroviral-Naive, HIV-1-Infected Volunteers (Abstract 09)
Coverage by Graeme Moyle, M.D.
Minor Interaction Between Efavirenz and Saquinavir When Combined with Small Doses of Ritonavir in a QD Regimen (Late Breaker Poster 9)
Coverage by Brian A. Boyle, M.D., J.D.

October 29, 2001

October 30, 2001

Return to The Body's coverage of
The 8th European Conference on Clinical Aspects and Treatment of HIV-Infection.

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.